Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma

Molecular Oncology

Volumn 7, Issue 6, 2013, Pages 1031-1042

  Damhofer, Helene ^a   Medema, Jan Paul ^a   Veenstra, Veronique L ^a   Badea, Liviu ^b   Popescu, Irinel ^c   Roelink, Henk ^d   Bijlsma, Maarten F ^a,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NATIONAL INSTITUTE FOR RESEARCH AND DEVELOPMENT IN INFORMATICS   (Romania)

^c FUNDENI CLINICAL INSTITUTE   (Romania)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Development; Hedgehog; mRNA Seq; Pancreatic cancer; Stroma

Indexed keywords

CYTIDINE DEAMINASE; DEVELOPMENTAL ENDOTHELIAL LOCUS 1 ISOFORM A PROTEIN; INTEGRIN BETA 4 ISOFORM 2; PROTEIN; SONIC HEDGEHOG PROTEIN; SPARC OSTEONECTIN CWCV AND KAZAL LIKE DOMAINS PROTEOGLYCAN 1; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CELL GROWTH; COCULTURE; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVERALL SURVIVAL; PANCREAS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SPECIES DIFFERENCE; STROMA;

ERINACEIDAE;

CDA; CYSTEINE DEAMINASE; DEVELOPMENT; EDIL3; EGF-LIKE REPEATS AND DISCOIDIN I-LIKE DOMAINS 3; GENE SET ENRICHMENT ANALYSIS; GSEA; HEDGEHOG; HH; INTEGRIN BETA 4; ITGB4; MRNA-SEQ; PANCREATIC CANCER; PANCREATIC DUCTAL ADENOCARCINOMA; PDAC; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTOR; PLAUR; SHH; SONIC HEDGEHOG; SPARC/OSTEONECTIN, CWCV AND KAZAL-LIKE DOMAINS PROTEOGLYCAN; SPOCK1; STROMA;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DISEASE-FREE SURVIVAL; FEMALE; HEDGEHOG PROTEINS; HUMANS; MALE; MICE; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; STROMAL CELLS; SURVIVAL RATE;

EID: 84887920070     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2013.08.004     Document Type: Article

References (32)

1. Aoka Y., Johnson F.L., Penta K., Hirata Ki K., Hidai C., Schatzman R., Varner J.A., Quertermous T. The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formation. Microvasc. Res. 2002, 64:148-161.
2. Badea L., Herlea V., Dima S.O., Dumitrascu T., Popescu I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 2008, 55:2016-2027.
3. Bailey J.M., Swanson B.J., Hamada T., Eggers J.P., Singh P.K., Caffery T., Ouellette M.M., Hollingsworth M.A. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin. Cancer Res. 2008, 14:5995-6004.
4. Berman D.M., Karhadkar S.S., Maitra A., Montes De Oca R., Gerstenblith M.R., Briggs K., Parker A.R., Shimada Y., Eshleman J.R., Watkins D.N., Beachy P.A. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003, 425:846-851.
5. Bijlsma M.F., Spek C.A., Peppelenbosch M.P. Hedgehog: an unusual signal transducer. Bioessays 2004, 26:387-394.
6. Burris H.A., Moore M.J., Andersen J., Green M.R., Rothenberg M.L., Modiano M.R., Cripps M.C., Portenoy R.K., Storniolo A.M., Tarassoff P., Nelson R., Dorr F.A., Stephens C.D., Von Hoff D.D. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J.Clin. Oncol. 1997, 15:2403-2413.
7. Cruz-Monserrate Z., Qiu S., Evers B.M., O'Connor K.L. Upregulation and redistribution of integrin alpha6beta4 expression occurs at an early stage in pancreatic adenocarcinoma progression. Mod. Pathol. 2007, 20:656-667.
8. Eda H., Ura M.,K.,F.O., Tanaka Y., Miwa M., Ishitsuka H. The antiproliferative activity of DMDC is modulated by inhibition of cytidine deaminase. Cancer Res. 1998, 58:1165-1169.
9. Ericson J., Morton S., Kawakami A., Roelink H., Jessell T.M. Two critical periods of Sonic Hedgehog signaling required for the specification of motor neuron identity. Cell 1996, 87:661-673.
10. Erkan M., Hausmann S., Michalski C.W., Fingerle A.A., Dobritz M., Kleeff J., Friess H. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat. Rev. Gastroenterol. Hepatol. 2012, 9:454-467.
11. Giancotti F.G. Targeting integrin beta4 for cancer and anti-angiogenic therapy. Trends Pharmacol. Sci. 2007, 28:506-511.
12. He Y., Liu X.D., Chen Z.Y., Zhu J., Xiong Y., Li K., Dong J.H., Li X. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. Clin. Cancer Res. 2007, 13:3115-3124.
13. Hulsen T., de Vlieg J., Alkema W. BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 2008, 9:488.
14. Li Y., Chen L., Chan T.H., Liu M., Kong K.L., Qiu J.L., Yuan Y.F., Guan X.Y. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice. Gastroenterology 2013, 144. 179-191e174.
15. Mahadevan D., Von Hoff D.D. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol. Cancer Ther. 2007, 6:1186-1197.
16. Mortazavi A., Williams B.A., McCue K., Schaeffer L., Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 2008, 5:621-628.
17. Neesse A., Michl P., Frese K.K., Feig C., Cook N., Jacobetz M.A., Lolkema M.P., Buchholz M., Olive K.P., Gress T.M., Tuveson D.A. Stromal biology and therapy in pancreatic cancer. Gut 2011, 60:861-868.
18. Olive K.P., Jacobetz M.A., Davidson C.J., Gopinathan A., McIntyre D., Honess D., Madhu B., Goldgraben M.A., Caldwell M.E., Allard D., Frese K.K., Denicola G., Feig C., Combs C., Winter S.P., Ireland-Zecchini H., Reichelt S., Howat W.J., Chang A., Dhara M., Wang L., Ruckert F., Grutzmann R., Pilarsky C., Izeradjene K., Hingorani S.R., Huang P., Davies S.E., Plunkett W., Egorin M., Hruban R.H., Whitebread N., McGovern K., Adams J., Iacobuzio-Donahue C., Griffiths J., Tuveson D.A. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324:1457-1461.
19. Pei H., Li L., Fridley B.L., Jenkins G.D., Kalari K.R., Lingle W., Petersen G., Lou Z., Wang L. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 2009, 16:259-266.
20. Planelles L., Medema J.P., Hahne M., Hardenberg G. The expanding role of APRIL in cancer and immunity. Curr. Mol. Med. 2008, 8:829-844.
21. Sinha S., Chen J.K. Purmorphamine activates the Hedgehog pathway by targeting Smoothened. Nat. Chem. Biol. 2006, 2:29-30.
22. Somasekaram A., Jarmuz A., How A., Scott J., Navaratnam N. Intracellular localization of human cytidine deaminase. Identification of a functional nuclear localization signal. J.Biol. Chem. 1999, 274:28405-28412.
23. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A 2005, 102:15545-15550.
24. Sun J.C., Liang X.T., Pan K., Wang H., Zhao J.J., Li J.J., Ma H.Q., Chen Y.B., Xia J.C. High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients. World J. Gastroenterol. 2010, 16:4611-4615.
25. Taipale J., Chen J.K., Cooper M.K., Wang B., Mann R.K., Milenkovic L., Scott M.P., Beachy P.A. Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature 2000, 406:1005-1009.
26. Teglund S., Toftgard R. Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim. Biophys. Acta. 2010, 1805:181-208.
27. Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernandez-del Castillo C., Yajnik V., Antoniu B., McMahon M., Warshaw A.L., Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, 425:851-856.
28. Vincent A., Herman J., Schulick R., Hruban R.H., Goggins M. Pancreatic cancer. Lancet 2011, 378:607-620.
29. Wang Z., Kundu R.K., Longaker M.T., Quertermous T., Yang G.P. The angiogenic factor Del1 prevents apoptosis of endothelial cells through integrin binding. Surgery 2012, 151:296-305.
30. Wichterle H., Lieberam I., Porter J.A., Jessell T.M. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002, 110:385-397.
31. Xue A., Scarlett C.J., Jackson C.J., Allen B.J., Smith R.C. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma. Pancreas 2008 March, 36(2):160-167.
32. Yauch R.L., Gould S.E., Scales S.J., Tang T., Tian H., Ahn C.P., Marshall D., Fu L., Januario T., Kallop D., Nannini-Pepe M., Kotkow K., Marsters J.C., Rubin L.L., de Sauvage F.J. A paracrine requirement for hedgehog signalling in cancer. Nature 2008, 455:406-410.